Celldex Therapeutics, Inc vs. Lantheus Holdings, Inc
Lantheus Holdings, Inc (LNTH) comes out ahead, leading on 2 of 2 compared factors.
Size & Scale
| CLDX | LNTH | |
|---|---|---|
| Market Cap | $3.02 billion | $6.56 billion |
| Revenue (TTM) | — | $1.56 billion |
| Net Income (TTM) | — | $275.31 million |
LNTH leads on 1 of 1 size & scale factors.
Valuation
| CLDX | LNTH | |
|---|---|---|
| P/E Ratio | — | 24.27 |
| Price / Book | — | 5.00 |
| Price / Sales | — | 4.21 |
CLDX and LNTH split the valuation factors evenly.
Profitability
| CLDX | LNTH | |
|---|---|---|
| Net Margin | — | 17.69% |
| Return on Equity | — | 20.99% |
CLDX and LNTH split the profitability factors evenly.
Risk & Sentiment
| CLDX | LNTH | |
|---|---|---|
| Short Interest | 9.28% | 0.72% |
LNTH leads on 1 of 1 risk & sentiment factors.
Dig deeper: CLDX overview, CLDX financials, LNTH overview, LNTH financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.